Leukemogenic rearrangements at the mixed lineage leukemia gene (MLL) - multiple rather than a single mechanism.
Despite manifold efforts to achieve reduced-intensity and -toxicity regimens, secondary leukemia has remained the most severe side effect of chemotherapeutic cancer treatment. Rearrangements involving a short telomeric <1kb region of the mixed lineage leukemia (MLL) gene are the most frequently o...
| الحاوية / القاعدة: | Frontiers in Cell and Developmental Biology |
|---|---|
| المؤلفون الرئيسيون: | , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Frontiers Media S.A.
2015-06-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://journal.frontiersin.org/Journal/10.3389/fcell.2015.00041/full |
